Category: director 
Researchers at the University of Delaware have discovered a new reason why the tall, tasseled reed Phragmites australis is one of the most invasive plants in the United States.
DALLAS -- June 3, 2009 -- A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.
BOSTON, Mass. (June 2, 2009) -- There are many reasons why health care costs in the US are spiraling out of control: ineffective use of resources, unmanaged chronic conditions and infrequent implementations of proven prevention strategies all contribute.
May 28, 2009 -- Scientists at Columbia University's Mailman School of Public Health, the South African National Institute for Communicable Diseases of National Health Laboratory Service (NICD-NHLS), the U.S.
CHAMPAIGN, Ill. -- Fast and affordable genome sequencing has moved a step closer with a new solid-state nanopore sensor being developed by researchers at the University of Illinois.
CHICAGO, IL (June 2, 2009) -- Researchers are making great strides in the development of new treatments for hepatitis and in confirming the effectiveness of current treatments, according to several studies being presented at Digestive Disease Week® 2009 (DDW®).
Researchers from the Institut Català de Paleontologia (ICP), from Universitat Autònoma de Barcelona, directed by professor Salvador Moyà-Solà, publish this week in the prestigious scientific journal Proceedings of the National Academy of Sciences, USA (PNAS) the results of their research regarding the find of a new genus of hominoid primate at els Hostalets de Pierola, l'Anoia.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
ANN ARBOR, Mich. -- Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study from the University of Michigan Comprehensive Cancer Center.
If you had cancer and a genetic test could predict the risk of the tumor spreading aggressively, would you want to know -- even if no treatments existed to help you?
An overwhelming majority of eye cancer patients would answer yes, according to a new UCLA study published in the June edition of the Journal of Genetic Counseling.
CHICAGO, IL (June 1, 2009) -- Researchers are making great strides in understanding the development and treatment of inflammatory bowel disease, a chronic inflammatory condition of the digestive tract that affects more than a half million Americans, according to several studies being presented at Digestive Disease Week® 2009 (DDW®).
In a new study, young children and their adult caregivers uttered fewer vocalizations, used fewer words and engaged in fewer conversations when in the presence of audible television. The population-based study is the first of its kind completed in the home environment, guided by lead researcher Dimitri A.
Citalopram (Celexa), a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to a multi-site clinical trial guided by lead author Bryan H.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
MANHASSET, NY -- A new multi-center study, conducted at The Feinstein Institute for Medical Research in collaboration with five other centers throughout the country, tested the commonly prescribed antidepressant citalopram and found that it was no more effective than placebo in altering obsessive features of the condition -- the spinning, rocking and repetitive behavior.
